Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Clofarabine in the treatment of poor risk acute myeloid leukaemia.
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study.
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia. Blood. 2021 11 25; 138(21):2066-2092.
View in:
PubMed
subject areas
Animals
Cell Line, Tumor
DNA-Binding Proteins
Female
Gene Expression Regulation, Leukemic
Humans
Leukemia, Myeloid, Acute
Male
Mice
MicroRNAs
Myeloid-Lymphoid Leukemia Protein
Oncogene Proteins, Fusion
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Preleukemia
Transcriptional Elongation Factors
Translocation, Genetic
authors with profiles
Michael Joseph O'Dwyer